Royal Philips has appointed Julia Strandberg as the chief business leader of its connected care businesses, effective April 24.
As of April 1, Philips’ connected care businesses will comprise the monitoring, sleep and respiratory care, and enterprise informatics businesses. Strandberg will become a member of Philips’ executive committee, reporting to CEO Roy Jakobs.
Strandberg joins the company from Pear Therapeutics, marketer of prescription digital cognitive behavioral therapy for insomnia Somryst and other digital therapeutics, where she served as chief commercial officer leading the commercial team that built, launched, and grew Pear’s prescription digital therapeutics offering.
Before this role, Strandberg led a healthcare business consulting firm focused on driving client growth, and prior to that, she led Medtronic’s global health informatics and monitoring business and was the global marketing leader for the patient monitoring business within Covidien’s respiratory and monitoring group, which was acquired by Medtronic.
Philips’ incoming chief business leader started her career at 3M, where she held various roles within the company.
“Julia brings deep, multi-disciplinary expertise, including in informatics and monitoring, to Philips,” says Roy Jakobs, CEO of Royal Philips, in a press release. “Passionate about improving the healthcare experience for patients and providers across care settings, Julia understands how to deliver in the global healthcare ecosystem and adds extensive experience in developing and commercializing medical technologies.”
Strandberg succeeds Dan Leonard, who took on the role of chief business leader connected care ad interim when Jakobs became CEO in October 2022.
Photo caption: Julia Strandberg joins Royal Philips as chief business leader of the connected care businesses.
Photo credit: Royal Philips